Informational Meeting: The Importation of Infectious Biological Agents, Infectious Substances and Vectors; Public Webinar, 56269 [2021-22044]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 193 / Friday, October 8, 2021 / Notices
1. The Vanguard Group, Inc.,
Malvern, Pennsylvania; on behalf of
itself, its subsidiaries and affiliates,
including investment companies
registered under the Investment
Company Act of 1940, other pooled
investment vehicles, and institutional
accounts that are sponsored, managed,
or advised by Vanguard; to acquire
additional voting shares of United
Community Banks, Inc., Blairsville,
Georgia, and thereby indirectly acquire
voting shares of United Community
Bank, of Greenville, South Carolina.
B. Federal Reserve Bank of Dallas
(Karen Smith, Director, Applications)
2200 North Pearl Street, Dallas, Texas
75201–2272:
1. The John H. Young 2020 Trust,
Edward E. Hartline and Gus K. Eifler as
co-trustees, all of Houston, Texas; to
acquire additional voting shares of
Central Bancshares, Inc., and thereby
indirectly acquire voting shares of
Central Bank, both of Houston, Texas.
Board of Governors of the Federal Reserve
System, October 5, 2021.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2021–22064 Filed 10–7–21; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Informational Meeting: The Importation
of Infectious Biological Agents,
Infectious Substances and Vectors;
Public Webinar
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of public webinar.
AGENCY:
The HHS/CDC’s Division of
Select Agents and Toxins (DSAT) is
hosting a public webinar to provide
information about import permit
regulations for infectious biological
agents, infectious substances, and
vectors. Besides the CDC, presenters
will include representatives from the
Department of Transportation, Animal
and Plant Health Inspection Service,
U.S. National Authority for
Containment of Poliovirus, Customs and
Border Protection, and the Department
of Commerce, who will discuss key
aspects involved in the importation of
infectious biological agents, infectious
substances, and vectors.
DATES: The webinar will be held
December 2, 2021 from 11:00 a.m. to
4:00 p.m. (EST). Registration
jspears on DSK121TN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:07 Oct 07, 2021
Jkt 256001
instructions are found on the HHS/CDC
Import Permit Program website, https://
www.cdc.gov/cpr/ipp/index.htm.
ADDRESSES: The webinar will be
broadcast from the Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Atlanta, Georgia 30329.
FOR FURTHER INFORMATION CONTACT:
Samuel S. Edwin, Ph.D., Director,
DSAT, Center for Preparedness and
Response, CDC, 1600 Clifton Road NE,
MS H–21–7, Atlanta, Georgia 30329.
Telephone: (404) 718–2000; email:
lrsat@cdc.gov.
SUPPLEMENTARY INFORMATION: This
webinar is an opportunity for all
interested parties (e.g., academic
institutions; biomedical centers;
commercial manufacturing facilities;
federal, state, and local laboratories,
including clinical and diagnostic
laboratories; research facilities;
exhibition facilities; and educational
facilities) to obtain specific guidance
and information regarding import
permit regulations and the shipment of
infectious biological materials. The
webinar will provide information to
those interested in applying for an
import permit from federal agencies
within the United States. Instructions
for registration are found on the CDC
Import Permit Program website, https://
www.cdc.gov/cpr/ipp/index.htm.
Participants must register by
November 26, 2021. This is a webinaronly event and there will be no on-site
participation at CDC.
Dated: October 4, 2021.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
[FR Doc. 2021–22044 Filed 10–7–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Placement and Transfer of
Unaccompanied Children Into ORR
Care Provider Facilities (0970–0554)
Office of Refugee Resettlement,
Administration for Children and
Families, Department of Health and
Human Services.
ACTION: Request for public comment.
AGENCY:
The Office of Refugee
Resettlement (ORR), Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS), is inviting public
comments on revisions to an approved
SUMMARY:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
56269
information collection. The request
consists of several forms that allow the
Unaccompanied Children (UC) Program
to place UC referred to ORR by federal
agencies into care provider facilities and
to transfer UC within the ORR care
provider network.
DATES: Comments due within 30 days of
publication. OMB must make a decision
about the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
SUPPLEMENTARY INFORMATION:
Description: ORR received several
comments on this information
collection in response to the Federal
Register Notice published on January
19, 2021, (86 FR 5196) and has provided
responses to those comments in its final
submission to OMB. UC Path is critical
to program operations and it is
important that rollout of the new system
not be delayed. Therefore, the below
description details what will be
included in the initial launch of the UC
Path case management system and
revisions based on public comments
will be made after initial launch. ORR
plans to conduct a deliberative review
of commenters’ suggestions and
concerns and submit a request for
revisions to this information collection
request in January 2022. The upcoming
information collection request will also
include revisions based on feedback
from UC Path system users (i.e., ORR
grantee, contractor, and federal staff).
A. ORR plans to revise all 13
instruments currently approved under
OMB #0970–0554, all of which will be
incorporated into ORR’s new case
management system, UC Path. Five of
the instruments contain revisions to the
formatting, organization, or wording of
field labels with no changes to the
content. The remaining eight
instruments contain changes in content.
In addition, ORR plans to add four new
instruments to this collection that will
also be incorporated into UC Path.
Finally, ORR plans to replace the term
‘‘unaccompanied alien child (UAC)’’
with ‘‘unaccompanied child (UC)’’
ADDRESSES:
E:\FR\FM\08OCN1.SGM
08OCN1
]]>Agencies
[Federal Register Volume 86, Number 193 (Friday, October 8, 2021)]
[Notices]
[Page 56269]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-22044]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Informational Meeting: The Importation of Infectious Biological
Agents, Infectious Substances and Vectors; Public Webinar
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of public webinar.
-----------------------------------------------------------------------
SUMMARY: The HHS/CDC's Division of Select Agents and Toxins (DSAT) is
hosting a public webinar to provide information about import permit
regulations for infectious biological agents, infectious substances,
and vectors. Besides the CDC, presenters will include representatives
from the Department of Transportation, Animal and Plant Health
Inspection Service, U.S. National Authority for Containment of
Poliovirus, Customs and Border Protection, and the Department of
Commerce, who will discuss key aspects involved in the importation of
infectious biological agents, infectious substances, and vectors.
DATES: The webinar will be held December 2, 2021 from 11:00 a.m. to
4:00 p.m. (EST). Registration instructions are found on the HHS/CDC
Import Permit Program website, https://www.cdc.gov/cpr/ipp/index.htm.
ADDRESSES: The webinar will be broadcast from the Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Atlanta, Georgia 30329.
FOR FURTHER INFORMATION CONTACT: Samuel S. Edwin, Ph.D., Director,
DSAT, Center for Preparedness and Response, CDC, 1600 Clifton Road NE,
MS H-21-7, Atlanta, Georgia 30329. Telephone: (404) 718-2000; email:
[email protected].
SUPPLEMENTARY INFORMATION: This webinar is an opportunity for all
interested parties (e.g., academic institutions; biomedical centers;
commercial manufacturing facilities; federal, state, and local
laboratories, including clinical and diagnostic laboratories; research
facilities; exhibition facilities; and educational facilities) to
obtain specific guidance and information regarding import permit
regulations and the shipment of infectious biological materials. The
webinar will provide information to those interested in applying for an
import permit from federal agencies within the United States.
Instructions for registration are found on the CDC Import Permit
Program website, https://www.cdc.gov/cpr/ipp/index.htm.
Participants must register by November 26, 2021. This is a webinar-
only event and there will be no on-site participation at CDC.
Dated: October 4, 2021.
Sandra Cashman,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2021-22044 Filed 10-7-21; 8:45 am]
BILLING CODE 4163-18-P
